Email Alert | RSS

北京大学学报（医学版） ›› 2022, Vol. 54 ›› Issue (5): 954-960. doi: 10.19723/j.issn.1671-167X.2022.05.024

• 论著 • 上一篇    下一篇

儿童直立不耐受和坐位不耐受的疾病谱及治疗方式十年回顾

崔雅茜1,杜军保1,2,张清友1,廖莹1,刘平1,王瑜丽1,齐建光1,闫辉1,徐文瑞1,刘雪芹1,孙燕1,孙楚凡1,张春雨1,陈永红1,金红芳1,*()   

  1. 1. 北京大学第一医院儿科, 北京 100034
    2. 教育部分子心血管学重点实验室, 北京 100191
  • 收稿日期:2022-06-03 出版日期:2022-10-18 发布日期:2022-10-14
  • 通讯作者: 金红芳 E-mail:jinhongfang51@126.com
  • 作者简介:金红芳，教授，研究员，博士生导师，北京大学第一医院儿科副主任，教育部长江学者青年学者，国家自然科学基金优秀青年基金获得者，国家高层次人才特殊支持计划(“万人计划”)青年拔尖人才，教育部新世纪优秀人才，北京市科技新星。担任Front Pediatr和Front Cardiovasc Med副主编，中国医师协会儿童重症医师分会心血管专业委员会主任委员，世界华人医师协会儿科医师分会心血管专业委员会主任委员，中华医学会儿科学分会心血管学组副组长，全国儿童心血管基础研究协作组组长。共发表SCI论文196篇，被引用4 229篇次，主持国家及部委级科研项目10余项，作为第一完成人获得教育部自然科学奖以及华夏医学科技奖，荣获茅以升科学技术奖——北京青年科技奖。
    在机体新的气体信号分子发现及儿科心血管疾病诊治领域取得突破性成就。首次发现并提出“内源性SO2是心血管调节的新的气体信号分子”，发现心血管系统存在内源性SO2的生成体系，揭示内源性SO2的心血管生理学意义以及病理生理学意义，阐明内源性SO2发挥生物学调节作用的分子机制，阐明气体信号分子H2S的表观调控机制，以及含硫气体信号分子间的相互作用及其生物学意义，进一步揭示了心血管疾病发病的新机制，推动形成了国际内源性SO2生物学研究的新领域。
    围绕影响儿童健康的重要疾病——儿童晕厥等功能性心血管病进行了系统、深入研究，在新疾病的发现、疾病的诊断技术与个体化治疗策略创立等方面取得了突出成绩。在国际上率先发现“儿童坐位不耐受”“坐位性心动过速综合征”“坐位性高血压”等导致儿童晕厥的系列新疾病，并通过全国多中心临床流行病学研究，建立了上述疾病的诊断标准，由此扩大了儿童晕厥及心血管病的基础疾病谱。在国内外首次建立了儿童晕厥个体化治疗决策体系，将儿童晕厥治疗有效率从65.6%提高至91.9%。应邀牵头主持撰写儿童青少年晕厥诊治国际指南，带动我国及国际116所医疗机构开展儿童晕厥及心血管疾病诊治工作，研究成果已推广至我国30个省(自治区、直辖市)以及英国、美国、日本
  • 基金资助:
    教育部长江学者奖励计划(青年学者)(Q2017004);北京市科技计划(Z171100001017253);中央高水平医院临床科研基金[北京大学第一医院国内多中心临床研究专项](2022CR59)

A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children

Ya-xi CUI1,Jun-bao DU1,2,Qing-you ZHANG1,Ying LIAO1,Ping LIU1,Yu-li WANG1,Jian-guang QI1,Hui YAN1,Wen-rui XU1,Xue-qin LIU1,Yan SUN1,Chu-fan SUN1,Chun-yu ZHANG1,Yong-hong CHEN1,Hong-fang JIN1,*()   

  1. 1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
    2. Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, China
  • Received:2022-06-03 Online:2022-10-18 Published:2022-10-14
  • Contact: Hong-fang JIN E-mail:jinhongfang51@126.com
  • Supported by:
    the Cheung Kong Scholars (Young Scholars) Award Program, Ministry of Education, China(Q2017004);Beijing Municipal Science and Technology Project(Z171100001017253);the National High Level Hospital Clinical Research Funding (Multi-center Clinical Research Project of Peking University First Hospital)(2022CR59)

RICH HTML

   

PDF (PC)

摘要：

目的: 分析儿童直立不耐受(orthostatic intolerance, OI)和坐位不耐受(sitting intolerance, SI)的基础疾病谱, 并了解其在临床上采用的经验性治疗方式。方法: 选择北京大学第一医院儿科2012年1月至2021年12月十年期间所有患儿的病例资料(包括病史、体格检查、实验室检查和影像学检查)进行回顾性分析, 将符合OI和SI诊断标准的患儿纳入研究, 分析患儿OI和SI的基础疾病谱, 并总结分析其治疗方式。结果: 共纳入OI和SI病例资料2 110例, 其中男943例(44.69%), 女1 167例(55.31%), 年龄4~18岁, 平均(11.34±2.84)岁。十年间总体OI和SI患儿例数呈逐渐增多趋势。OI疾病谱中占比最高的是体位性心动过速综合征(postural orthostatic tachycardia syndrome, POTS), 共826例(39.15%); 其次为血管迷走性晕厥(vasovagal syncope, VVS), 共634例(30.05%)。而SI疾病谱中占比最高的是坐位性心动过速综合征(sitting tachycardia syndrome, STS), 共8例(0.38%); 其次为坐位性高血压(sitting hypertension, SHT) 2例(0.09%); 此外, OI和SI合并疾病中占比最多的是POTS合并STS, 共36例(1.71%)。在OI和SI治疗方式中, 主要为自主神经功能锻炼757例(35.88%), 其次为口服补液盐(oral rehydration salts, ORS) 687例(32.56%), 美托洛尔307例(14.55%), 盐酸米多君142例(6.73%), ORS联合美托洛尔138例(6.54%)和ORS联合盐酸米多君79例(3.74%)。POTS合并VVS的患儿相对于POTS或VVS患儿, 接受药物治疗者更多(41.95% vs. 30.51% vs. 28.08%, χ2= 20.319, P < 0.01), 而POTS和VVS患儿的药物治疗占比没有统计学差异。结论: 儿童POTS及VVS是OI的主要基础疾病, SI是近年来新发现的疾病。OI和SI患儿的人数整体呈逐渐增加的趋势, 其主要治疗方式为自主神经功能锻炼和口服ORS。POTS合并VVS的患儿相对于单纯POTS或VVS患儿, 更倾向于接受药物治疗。

关键词: 儿童, 直立不耐受, 坐位不耐受, 疾病谱

Abstract:

Objective: To analyze the disease spectrums underlying orthostatic intolerance (OI) and sitting intolerance (SI) in Chinese children, and to understand the clinical empirical treatment options. Methods: The medical records including history, physical examination, laboratory examination, and imagological examination of children were retrospectively studied in Peking University First Hospital from 2012 to 2021. All the children who met the diagnostic criteria of OI and SI were enrolled in the study. The disease spectrums underlying OI and SI and treatment options during the last 10 years were analyzed. Results: A total of 2 110 cases of OI and SI patients were collected in the last 10 years, including 943 males (44.69%) and 1 167 females (55.31%) aged 4－18 years, with an average of (11.34±2.84) years. The overall case number was in an increasing trend over the year. In the OI spectrum, postural tachycardia syndrome (POTS) accounted for 826 cases (39.15%), followed by vasovagal syncope (VVS) (634 cases, 30.05%). The highest proportion of SI spectrum was sitting tachycardia (STS) (8 cases, 0.38%), followed by sitting hypertension (SHT) (2 cases, 0.09%). The most common comorbidity of OI and SI was POTS coexisting with STS (36 cases, 1.71%). The highest proportion of treatment options was autonomic nerve function exercise (757 cases, 35.88%), followed by oral rehydration salts (ORS) (687 cases, 32.56%), metoprolol (307 cases, 14.55%), midodrine (142 cases, 6.73%), ORS plus metoprolol (138 cases, 6.54%), and ORS plus midodrine (79 cases, 3.74%). The patients with POTS coexisting with VVS were more likely to receive pharmacological intervention than the patients with POTS and the patients with VVS (41.95% vs. 30.51% vs. 28.08%, χ2= 20.319, P < 0.01), but there was no significant difference in the proportion of treatment options between the patients with POTS and the patients with VVS. Conclusion: POTS and VVS in children are the main underlying diseases of OI, while SI is a new disease discovered recently. The number of children with OI and SI showed an increasing trend. The main treatment methods are autonomic nerve function exercise and ORS. Children with VVS coexisting with POTS were more likely to take pharmacological treatments than those with VVS or POTS only.

Key words: Children, Orthostatic intolerance, Sitting intolerance, Disease spectrum

中图分类号: 

  • R725

图1

不同年份OI和SI患儿人数变化"

表1

直立不耐受和坐位不耐受患儿的疾病谱变化"

Disease 2012 to 2016 2017 to 2021
Total Male Female Total Male Female
POTS 478 (49.64) 217 (45.40) 261 (54.60) 348 (30.34) 153 (43.97) 195 (56.03)
VVS 300 (31.15) 130 (43.33) 170 (56.67) 334 (29.12) 147 (44.01) 187 (55.99)
POTS + VVS 48 (4.98) 26 (54.17) 22 (45.83) 281 (24.50) 104 (37.01) 177 (62.99)
POTS + OHT 57 (5.92) 34 (59.65) 23 (40.35) 29 (2.53) 16 (55.17) 13 (44.83)
OHT 65 (6.75) 31 (47.69) 34 (52.31) 11 (0.96) 6 (54.55) 5 (45.45)
OH 8 (0.83) 4 (50.00) 4 (50.00) 18 (1.57) 9 (50.00) 9 (50.00)
VVS + OHT 5 (0.52) 4 (80.00) 1 (20.00) 22 (1.92) 14 (63.64) 8 (36.36)
POTS + VVS + OHT 2 (0.21) 1 (50.00) 1 (50.00) 20 (1.74) 8 (40.00) 12 (60.00)
POTS + VVS + STS - - - 26 (2.26) 7 (26.92) 19 (73.08)
POTS + STS - - - 36 (3.14) 19 (52.78) 17 (47.22)
VVS + STS - - - 8 (0.70) 4 (50.00) 4 (50.00)
STS - - - 8 (0.70) 5 (62.50) 3 (37.35)
SHT - - - 2 (0.17) 2 (100.00) 0 (0.00)
OHT + SHT - - - 1 (0.09) 1 (100.00) 0 (0.00)
POTS + OHT + STS + SHT - - - 3 (0.26) 1 (33.33) 2 (66.67)
Total 963 447 (46.42) 516 (53.58) 1 147 496 (43.24) 651 (56.76)

表2

POTS、VVS以及POTS合并VVS三组患儿的治疗方式分析"

Treatment options POTS VVS POTS + VVS
Autonomic nervous function exercise 297 (35.96) 211 (33.28) 108 (32.83)
ORS 277 (33.53) 245 (38.64) 83 (25.23)
Metoprolol 140 (16.95) 60 (9.46) 42 (12.77)
Midodrine 43 (5.21) 55 (8.68) 34 (10.33)
ORS plus metoprolol 47 (5.69) 37 (5.84) 36 (10.94)
ORS plus midodrine 22 (2.66) 26 (4.10) 26 (7.90)
Total 826 634 329

表3

POTS、VVS以及POTS合并VVS三组患儿接受药物和非药物治疗构成分析"

Treatment options POTS VVS POTS + VVS
Non-pharmacological 574 (69.49) 456 (71.92) 191 (58.05)
Pharmacological 252 (30.51) 178 (28.08) 138 (41.95)
Total 826 634 329
1 魏红芳, 董湘玉, 肖要. 儿童直立不耐受与微观营养素和体质指数相关性研究进展[J]. 中国循证儿科杂志, 2019, 14 (6): 473.
doi: 10.3969/j.issn.1673-5501.2019.06.017
2 Anderson JB , Willis M , Lancaster H , et al. The evaluation and management of pediatric syncope[J]. Pediatr Neurol, 2016, 55, 6- 13.
doi: 10.1016/j.pediatrneurol.2015.10.018
3 Jug J , Lovrić Benčić M , Bradić L , et al. Depression, anxiety and quality of life in patients with syncope[J]. Psychiatr Danub, 2020, 32 (3/4): 442- 443.
4 Kara A , Doǧan MT . The psychopathology, depression, and anxiety levels of children and adolescents with vasovagal syncope: A case-control study[J]. J Nerv Ment Dis, 2021, 209 (8): 547- 551.
doi: 10.1097/NMD.0000000000001334
5 Zhao J , Han Z , Zhang X , et al. A cross-sectional study on upright heart rate and BP changing characteristics: Basic data for estab-lishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension[J]. BMJ open, 2015, 5 (6): e007356.
doi: 10.1136/bmjopen-2014-007356
6 Lin J , Wang Y , Ochs T , et al. Tilt angles and positive response of head-up tilt test in children with orthostatic intolerance[J]. Cardiol Young, 2015, 25 (1): 76- 80.
doi: 10.1017/S1047951113001601
7 尚丽丽, 彭宇阁, 刘佳, 等. 直立倾斜试验在儿童不明原因晕厥诊断中的应用[J]. 中国实用神经疾病杂志, 2019, 22 (18): 2026- 2031.
8 王利平, 杜忠东, 柴晓敏, 等. 舌下含服硝酸甘油直立倾斜试验对儿童血管迷走性晕厥的诊断价值[J]. 临床儿科杂志, 2006, 24 (5): 364- 366.
doi: 10.3969/j.issn.1000-3606.2006.05.007
9 张清友, 杜军保, 李万镇. 舌下含化硝酸甘油直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 2004, 42 (5): 371- 374.
doi: 10.3760/j.issn:0578-1310.2004.05.016
10 Tao C , Han Z , Yan Y , et al. Sitting-induced hemodynamic changes and association with sitting intolerance in children and adolescents: A cross-sectional study[J]. Sci Rep, 2020, 10 (1): 13921.
doi: 10.1038/s41598-020-70925-y
11 Wang C , Li Y , Liao Y , et al. 2018 Chinese pediatric cardiology society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents[J]. Sci Bull, 2018, 63 (23): 1558- 1564.
doi: 10.1016/j.scib.2018.09.019
12 宋婧媛, 王圆圆, 李红霞, 等. 儿童血管迷走性晕厥发病机制研究进展[J]. 中华实用儿科临床杂志, 2018, 33 (6): 478- 480.
doi: 10.3760/cma.j.issn.2095-428X.2018.06.020
13 Magkas N , Tsioufis C , Thomopoulos C , et al. Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations[J]. J Clin Hypertens (Greenwich), 2019, 21 (5): 546- 554.
doi: 10.1111/jch.13521
14 Zhang Q , Li J , Xie Y , et al. Orthostatic hypertension in children and adolescents with postural tachycardia syndrome[J]. J Trop Pediatr, 2014, 60 (6): 461- 466.
doi: 10.1093/tropej/fmu055
15 Brignole M , Moya A , de Lange FJ , et al. 2018 ESC guidelines for the diagnosis and management of syncope[J]. Eur Heart J, 2018, 39 (21): 1883- 1948.
doi: 10.1093/eurheartj/ehy037
16 蔺婧, 王瑜丽, 张清友, 等. 儿童青少年晕厥疾病谱近30年变化及卫生经济学分析单中心报告[J]. 中国实用儿科杂志, 2016, 31 (5): 350- 355.
17 杜军保, 李万镇. 基础直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 1997, 35 (6): 309- 312.
doi: 10.3760/j.issn:0578-1310.1997.06.008
18 张清友, 杜军保, 李万镇. 儿童体位性心动过速综合征的临床特征及随访研究[J]. 中华儿科杂志, 2005, 43 (3): 165- 169.
doi: 10.3760/j.issn:0578-1310.2005.03.002
19 钟睛. 儿童直立不耐受559例临床分析[D]. 济南: 山东大学, 2019.
20 Cai H , Wang S , Zou R , et al. Comparison of the active sitting test and head-up tilt test for diagnosis of postural tachycardia syndrome in children and adolescents[J]. Front Pediatr, 2021, 9, 691390.
doi: 10.3389/fped.2021.691390
21 Kanjwal K , Sheikh M , Karabin B , et al. Neurocardiogenic syncope coexisting with postural orthostatic tachycardia syndrome in patients suffering from orthostatic intolerance: A combined form of autonomic dysfunction[J]. Pacing Clin Electrophysiol, 2011, 34 (5): 549- 554.
doi: 10.1111/j.1540-8159.2010.02994.x
22 Tao C , Jin H , Du J . Management of orthostatic intolerance in children: the state of the art[J]. World J Pediatr, 2020, 16 (6): 543- 548.
doi: 10.1007/s12519-019-00329-0
23 Kaufmann H , Norcliffe-Kaufmann L , Palma JA . Baroreflex dysfunction[J]. N Engl J Med, 2020, 382 (2): 163- 178.
doi: 10.1056/NEJMra1509723
24 Iacoviello M , Guida P , Forleo C , et al. Impaired arterial baroreflex function before nitrate-induced vasovagal syncope during head-up tilt test[J]. Europace, 2008, 10 (10): 1170- 1175.
doi: 10.1093/europace/eun217
25 肖要, 张小华, 魏红芳, 等. 儿童直立不耐受发病机制研究进展[J]. 兰州大学学报(医学版), 2021, 47 (6): 82- 88.
26 Mitro P , Mudráková K , Micková H , et al. Hemodynamic parameters and heart rate variability during a tilt test in relation to gene polymorphism of renin-angiotensin and serotonin system[J]. Pacing Clin Electrophysiol, 2008, 31 (12): 1571- 1580.
doi: 10.1111/j.1540-8159.2008.01228.x
27 Stewart JM , Medow MS , Sutton R , et al. Mechanisms of vasovagal syncope in the young: reduced systemic vascular resistance versus reduced cardiac output[J]. J Am Heart Assoc, 2017, 6 (1): e004417.
doi: 10.1161/JAHA.116.004417
28 Bai W , Chen S , Jin H , et al. Vascular dysfunction of postural tachycardia syndrome in children[J]. World J Pediatr, 2018, 14 (1): 13- 17.
doi: 10.1007/s12519-017-0104-8
29 Mosqueda-Garcia R , Furlan R , Tank J , et al. The elusive pathophysiology of neurally mediated syncope[J]. Circulation, 2000, 102 (23): 2898- 2906.
doi: 10.1161/01.CIR.102.23.2898
30 Liao Y , Du J . Pathophysiology and individualized management of vasovagal syncope and postural tachycardia syndrome in children and adolescents: An update[J]. Neurosci Bull, 2020, 36 (6): 667- 681.
doi: 10.1007/s12264-020-00497-4
[1] 李宗瀚, 黄洋阅, 李宁, 李明磊, 宋宏程, 张潍平, 刘超. 国产单孔蛇形臂机器人手术系统在儿童肾盂成形术中的应用[J]. 北京大学学报（医学版）, 2025, 57(4): 662-665.
[2] 赵兆, 张维宇, 杨文博, 张勇杰, 张晓鹏, 赵慧颖, 周刚, 王强. 低龄、低体重儿童肾移植2例[J]. 北京大学学报（医学版）, 2025, 57(4): 803-807.
[3] 张依航, 蔡珊, 陈子玥, 刘云飞, 党佳佳, 师嫡, 李佳欣, 黄天彧, 宋逸. 基于RE-AIM框架儿童青少年近视与肥胖共病综合干预实施性研究结局指标的构建[J]. 北京大学学报（医学版）, 2025, 57(3): 436-441.
[4] 唐孟利, 刘扬, 秦冉, 郭欣, 李宏田. 我国10省幼儿园5~6岁儿童近视和近视前期流行特征[J]. 北京大学学报（医学版）, 2025, 57(3): 442-447.
[5] 刘光旭, 张良, 赵厚宇, 邓思危, 杨君婷, 李宁, 马瑞, 何艳, 许国章, 刘志科, 詹思延. 2015—2021年宁波市6岁以下儿童热性惊厥的流行病学特征[J]. 北京大学学报（医学版）, 2025, 57(3): 584-591.
[6] 李琳, 廖津津. 应用ROC曲线评估久坐行为对儿童青少年视力不良的预测价值[J]. 北京大学学报（医学版）, 2025, 57(3): 614-619.
[7] 王紫薇, 李闵, 高慧, 邓芳. 链球菌感染与过敏性紫癜肾炎患儿肾损害的相关性[J]. 北京大学学报（医学版）, 2025, 57(2): 284-290.
[8] 邓敏婷, 王楠, 夏斌, 赵玉鸣, 朱俊霞. 儿童及青少年挫入恒前牙自行再萌出的相关影响因素[J]. 北京大学学报（医学版）, 2025, 57(1): 148-153.
[9] 杨颖婷, 李若竹, 窦桂丽, 雷玥, 夏斌. iRoot BP Plus用于年轻恒牙外伤部分牙髓切断治疗的临床随机对照研究[J]. 北京大学学报（医学版）, 2024, 56(6): 1083-1088.
[10] 赵双云, 邹思雨, 李雪莹, 沈丽娟, 周虹. 中文版口腔健康素养量表简版(HeLD-14)在学龄前儿童家长中应用的信度和效度评价[J]. 北京大学学报（医学版）, 2024, 56(5): 828-832.
[11] 陈心心, 唐哲, 乔艳春, 荣文笙. 北京市密云区4岁儿童患龋状况及其与龋活跃性检测的相关性[J]. 北京大学学报（医学版）, 2024, 56(5): 833-838.
[12] 岳芷涵,韩娜,鲍筝,吕瑾莨,周天一,计岳龙,王辉,刘珏,王海俊. 儿童早期体重指数轨迹与超重风险关联的前瞻性队列研究[J]. 北京大学学报（医学版）, 2024, 56(3): 390-396.
[13] 费秀文,刘斯,汪波,董爱梅. 成人及儿童组织坏死性淋巴结炎临床特征及治疗[J]. 北京大学学报（医学版）, 2024, 56(3): 533-540.
[14] 俞光岩. 儿童唾液腺疾病[J]. 北京大学学报（医学版）, 2024, 56(1): 1-3.
[15] 闫晓晋,刘云飞,马宁,党佳佳,张京舒,钟盼亮,胡佩瑾,宋逸,马军. 《中国儿童发展纲要(2011-2020年)》实施期间中小学生营养不良率变化及其政策效应分析[J]. 北京大学学报（医学版）, 2023, 55(4): 593-599.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部